Novo Resources Corp has significantly advanced exploration at its John Bull Gold Project in New South Wales, with mapping and geochemical work identifying high-priority drill targets within a structurally controlled intrusion-related gold system.
The company’s soil sampling extended the >100 parts per billion (ppb) gold anomaly to 1.5 kilometres of strike, with a peak soil result up to 1.59 grams per tonne (g/t) gold, while rock chip sampling returned grades as high as 67.9 g/t and 29 g/t gold from quartz vein systems. A 1,500-metre reverse circulation (RC) drilling program is expected to start in June 2025, subject to rig availability and final approvals.
GoviEx Uranium Inc (TSX-V:GXU, OTCQX:GVXXF) said on Monday it had closed a C$10.5 million upsized private placement, anchored by a privately held Zambian investment group, strengthening its development plans for the Muntanga uranium project in Zambia.
The financing saw the sale of 209.4 million units at C$0.05 each, with each unit comprising one common share and a warrant exercisable at US$0.051 until May 2027.
Ocean Power Technologies Inc (NYSE-A:OPTT) said on Monday it has been awarded a contract to supply multiple unmanned surface vehicles to Allied Forces.
The agreement, which includes the delivery of WAM-V vehicles, integrated sensors, and operational services under a contractor-owned, contractor-operated model, is scheduled for fulfillment in late spring 2025.
Tamboran Resource Corporation has appointed seasoned investment manager Jeff Bellman as a non-executive director, bolstering its board as the company progresses towards first gas production from the Beetaloo Basin in the Northern Territory.
Bellman brings more than three decades of experience in the investment management industry, with a core focus on the global oil and gas sector. He has managed equity portfolios across a broad range of market capitalisations, developing enduring relationships with energy sector management teams over a 33-year career.
In the quarter just gone, Cobalt Blue Holdings Ltd worked on its refining and exploration portfolio, with a focus on its flagship Kwinana Cobalt Refinery (KCR).
The is also laid plans to strategically diversify through the Halls Creek Project and by executing key corporate and funding initiatives.
Elixir Energy Ltd made significant strides during the March 2025 quarter, enhancing its presence in the Taroom Trough with key exploration and commercial milestones. The company successfully executed a farm-in agreement with Santos for permits ATP 2056 and ATP 2057, securing a 50% interest and boosting its net Contingent Resources by 1.2 trillion cubic feet equivalent (TCFe). This positions Elixir as the holder of the largest net acreage in the basin.
Elixir also raised A$7 million through a placement and opened a Share Purchase Plan to raise up to A$2 million more.
Cadoux Ltd made significant progress across its high purity alumina (HPA) and Minhub rare earths projects during the March 2025 quarter. Key milestones included the ramp-up of Front-End Engineering and Design (FEED) studies for its HPA Small Scale Plant (SSP) in Kwinana, Western Australia, and finalisation of the draft feasibility study for the Minhub mineral separation facility in Darwin.
The company continued its engineering optimisation, appointed key service providers, and expanded downstream product trials with university partners. It also received around A$687,000 in R&D rebate related to Minhub and saw favourable early-stage customer assessments of its HPA product for electric vehicle and energy storage applications.
Cyprium Metals Ltd progressed towards the restart of its Nifty Copper Complex during the March 2025 quarter, while formalising a strategic alliance with Macmahon Holdings Ltd to execute the next phase of development.
The company also advanced work on its broader Paterson Province portfolio, including a significant mineral resource estimate (MRE) upgrade at Maroochydore, and generated additional capital through non-core asset divestments. Cash at the end of the quarter stood at A$17 million, with further proceeds expected from asset sales.
GTI Energy Ltd made steady progress at its Lo Herma in-situ recovery (ISR) uranium project in Wyoming during the March 2025 quarter, with key fieldwork and laboratory testing completed in support of the upcoming scoping study.
The company reported positive uranium leach results from agitation tests, achieving recoveries of up to 80%, consistent with other ISR operations in the Powder River Basin. All groundwater monitoring wells returned favourable data, confirming the mineralisation lies well within the saturated aquifer, supporting the ISR mining method.
Apollo Minerals Ltd has fielded some strong results from its Phase 2 diamond drilling program at the Salanie Gold Project in Gabon, with high-grade intersections and visible quartz-sulphide mineralisation across multiple targets including at the historically productive P6 and A1 prospects.
The company has received assay results for the first eight of 14 holes drilled in the 2025 campaign, with assays from five holes pending.
Following a positive Definitive Feasibility Study (DFS) in the March quarter, Lithium Universe Ltd confirmed its decision to proceed with funding for the Bécancour Lithium Refinery in Québec, Canada,
The project has been assessed as economically viable, delivering a strong pre-tax net present value (NPV) at an 8% discount rate of approximately US$718 million. A pre-tax internal rate of return (IRR) of 21.0% and a payback period of 3.9 years are based on key pricing assumptions of US$1,170 per tonne for spodumene concentrate (SC6) and US$20,970 per tonne for battery-grade lithium carbonate (Li₂CO₃).
European Lithium Ltd had a robust March quarter on several fronts, capped off by a 45 million tonne maiden resource at its flagship Tanbreez Rare Earth Project in Greenland.
The company also made further progress across its European and global critical minerals portfolio, including infrastructure expansion at its Wolfsberg Project in Austria, and enters the June quarter well positioned to capitalise on growing demand for rare earths and lithium from and for Western markets.
Race Oncology Ltd has bolstered its clinical leadership team with the appointment of Dr Jose Iglesias as chief medical officer and Dr Simon Fisher as vice president of Clinical, as it accelerates development of its lead oncology candidate, RC220.
RC220 is a reformulated bisantrene therapy, developed to target solid tumours and acute myeloid leukaemia, with the aim of enhancing efficacy and reducing cardiotoxicity.